- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Canadian Customs to levy tariffs on Nycomed
The Canadian Customs and Revenue Agency has decided to assess duties on Nycomed Amersham Imaging’s Omnipaque and Visipaque, according to Nycomed Amersham Canada. The move came after Mallinckrodt Medical alleged in June that Oakville, Ontario-based
The Canadian Customs and Revenue Agency has decided to assess duties on Nycomed Amersham Imagings Omnipaque and Visipaque, according to Nycomed Amersham Canada. The move came after Mallinckrodt Medical alleged in June that Oakville, Ontario-based Nycomed Amersham Canada was dumping its products on the Canadian market. On Nov. 15, the Canadian commissioner of customs and revenue extended the period of investigation for the charges, and on Dec. 31, made a preliminary determination that dumping had occurred. Nycomed Amersham Canada plans to contest the decision before the Canadian International Trade Tribunal, according to Jean-Pierre Huot, general manager. The tribunal will hold hearings on the case in March, Huot said.
New Study Assesses Benefits of High-Resolution Photon-Counting for Computed Tomography Angiography
October 10th 2024Researchers found that ultra-high resolution photon-counting significantly enhanced visualization of small vessels and facilitated improved reduction of blooming artifacts for head and neck computed tomography angiography (CTA) scans.
Multicenter Study Identifies Key Factors Associated with Mammogram-Occult Ipsilateral Breast Cancer
October 9th 2024A symptomatic first breast cancer diagnosis, prevailing breast density at a second breast cancer diagnosis and trabecular thickening on surveillance mammography were linked to mammogram-occult ipsilateral breast cancer, according to new research.
